Drug intelligence / Profile preview

fexofenadine + phenylephrine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Fexofenadine + phenylephrine is an oral pharmaceutical combination of two small molecule drugs—**fexofenadine**, a selective antihistamine (histamine H1 receptor antagonist), and **phenylephrine**, a sympathomimetic decongestant. Fexofenadine works by blocking histamine H1 receptors on effector cells in blood vessels and respiratory tract, thereby inhibiting the actions of endogenous histamine responsible for allergy symptoms[3]. Phenylephrine exerts its effect mainly through stimulation of alpha-adrenergic receptors, leading to vasoconstriction of blood vessels in nasal mucosa, which reduces swelling and congestion[2]. The combination is primarily indicated for relief of allergic symptoms such as sneezing, runny nose, and nasal congestion caused by allergic rhinitis or the common cold[2].

02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on fexofenadine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fexofenadine + phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call